Skip to main content
NCBI home page
Heart logoLink to Heart
. 2000 Feb;83(2):247–252. doi: 10.1136/heart.83.2.247

Atherogenesis: current understanding of the causes of atheroma

P Weissberg 1
PMCID: PMC1729321  PMID: 10648506

Full Text

The Full Text of this article is available as a PDF (210.7 KB).

Figure 1:  .

Figure 1:  

Open in a new tab

Cellular interactions in the development and progression of atherosclerosis. VSMC, vascular smooth muscle cells.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bennett M. R., Macdonald K., Chan S. W., Boyle J. J., Weissberg P. L. Cooperative interactions between RB and p53 regulate cell proliferation, cell senescence, and apoptosis in human vascular smooth muscle cells from atherosclerotic plaques. Circ Res. 1998 Apr 6;82(6):704–712. doi: 10.1161/01.res.82.6.704. [DOI] [PubMed] [Google Scholar]
  2. Callister T. Q., Raggi P., Cooil B., Lippolis N. J., Russo D. J. Effect of HMG-CoA reductase inhibitors on coronary artery disease as assessed by electron-beam computed tomography. N Engl J Med. 1998 Dec 31;339(27):1972–1978. doi: 10.1056/NEJM199812313392703. [DOI] [PubMed] [Google Scholar]
  3. Davies M. J. Stability and instability: two faces of coronary atherosclerosis. The Paul Dudley White Lecture 1995. Circulation. 1996 Oct 15;94(8):2013–2020. doi: 10.1161/01.cir.94.8.2013. [DOI] [PubMed] [Google Scholar]
  4. Falk E., Shah P. K., Fuster V. Coronary plaque disruption. Circulation. 1995 Aug 1;92(3):657–671. doi: 10.1161/01.cir.92.3.657. [DOI] [PubMed] [Google Scholar]
  5. Libby P. Molecular bases of the acute coronary syndromes. Circulation. 1995 Jun 1;91(11):2844–2850. doi: 10.1161/01.cir.91.11.2844. [DOI] [PubMed] [Google Scholar]
  6. McNamara C. A., Sarembock I. J., Bachhuber B. G., Stouffer G. A., Ragosta M., Barry W., Gimple L. W., Powers E. R., Owens G. K. Thrombin and vascular smooth muscle cell proliferation: implications for atherosclerosis and restenosis. Semin Thromb Hemost. 1996;22(2):139–144. doi: 10.1055/s-2007-999001. [DOI] [PubMed] [Google Scholar]
  7. Ridker P. M., Cushman M., Stampfer M. J., Tracy R. P., Hennekens C. H. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 1997 Apr 3;336(14):973–979. doi: 10.1056/NEJM199704033361401. [DOI] [PubMed] [Google Scholar]
  8. Rosenson R. S., Tangney C. C. Antiatherothrombotic properties of statins: implications for cardiovascular event reduction. JAMA. 1998 May 27;279(20):1643–1650. doi: 10.1001/jama.279.20.1643. [DOI] [PubMed] [Google Scholar]
  9. Ross R., Glomset J. A. The pathogenesis of atherosclerosis (first of two parts). N Engl J Med. 1976 Aug 12;295(7):369–377. doi: 10.1056/NEJM197608122950707. [DOI] [PubMed] [Google Scholar]
  10. Ross R., Wight T. N., Strandness E., Thiele B. Human atherosclerosis. I. Cell constitution and characteristics of advanced lesions of the superficial femoral artery. Am J Pathol. 1984 Jan;114(1):79–93. [PMC free article] [PubMed] [Google Scholar]
  11. Shanahan C. M., Weissberg P. L. Smooth muscle cell heterogeneity: patterns of gene expression in vascular smooth muscle cells in vitro and in vivo. Arterioscler Thromb Vasc Biol. 1998 Mar;18(3):333–338. doi: 10.1161/01.atv.18.3.333. [DOI] [PubMed] [Google Scholar]
  12. Shepherd J., Cobbe S. M., Ford I., Isles C. G., Lorimer A. R., MacFarlane P. W., McKillop J. H., Packard C. J. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med. 1995 Nov 16;333(20):1301–1307. doi: 10.1056/NEJM199511163332001. [DOI] [PubMed] [Google Scholar]
  13. Toussaint J. F., LaMuraglia G. M., Southern J. F., Fuster V., Kantor H. L. Magnetic resonance images lipid, fibrous, calcified, hemorrhagic, and thrombotic components of human atherosclerosis in vivo. Circulation. 1996 Sep 1;94(5):932–938. doi: 10.1161/01.cir.94.5.932. [DOI] [PubMed] [Google Scholar]
  14. Treasure C. B., Klein J. L., Weintraub W. S., Talley J. D., Stillabower M. E., Kosinski A. S., Zhang J., Boccuzzi S. J., Cedarholm J. C., Alexander R. W. Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. N Engl J Med. 1995 Feb 23;332(8):481–487. doi: 10.1056/NEJM199502233320801. [DOI] [PubMed] [Google Scholar]
  15. Williams J. K., Sukhova G. K., Herrington D. M., Libby P. Pravastatin has cholesterol-lowering independent effects on the artery wall of atherosclerotic monkeys. J Am Coll Cardiol. 1998 Mar 1;31(3):684–691. doi: 10.1016/s0735-1097(97)00537-8. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

[Additional References]
heart_83_2_247__index.html (7.1KB, html)

Articles from Heart are provided here courtesy of BMJ Publishing Group

RESOURCES